DRUG REACTIONS - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

DRUG REACTIONS

Description:

A drug may be defined as a chemical substance, ... Erythema multiforme Stevens-Johnson syndrome Toxic epidermal necrolysis – PowerPoint PPT presentation

Number of Views:233
Avg rating:3.0/5.0
Slides: 32
Provided by: DrMa82
Category:

less

Transcript and Presenter's Notes

Title: DRUG REACTIONS


1
DRUG REACTIONS
  • A drug may be defined as a chemical substance, or
    combination of substances, administered for the
    investigation, prevention or treatment of
    diseases or symptoms, real or imagined.
  • The distinction between drugs and 'other
    chemicals' is not always easily

2
  • Chemicals of very diverse structure are
    increasingly added to foods and beverages as
    dyes, flavours or preservatives.
  • Chemicals used in agriculture or in veterinary
    medicine may contaminate human
  • Advent of therapeutic agents that may be useful
    for improving the appearance, e.g minoxidil for
    androgenetic alopecia and tretinoin for
    photo-aged skin,
  • the distinction between drugs and cosmetics has
    become blurred

3
  • An adverse drug reaction - defined as an
    undesirable clinical manifestation resulting from
    administration of a particular drug at doses
    normally used for prophylaxix,diagnosis threapy
    of diseases WHO 1972
  • this includes reactions due to overdose,
    predictable side-effects and unanticipated
    adverse manifestations.
  • Adverse drug reactions are the inevitable price
    we pay for the benefits of modern drug therapy.
  • They are costly both in terms of -
  • the human illness caused
  • in economic terms,
  • can undermine doctor-patient relationship.

4
  • Adverse drug reactions contribute to the need for
    hospitalization in 10-17 of elderly inpatients
  • Inappropriate medication is a major cause of
    adverse drug reactions in elderly patients
  • 27 of elderly patients on medication admitted to
    a teaching hospital experienced adverse drug
    reactions,
  • Adverse drug reactions occur in between 6 and 17
    of children admitted to specialist paediatric
    hospitals

5
  • The incidence of adverse drug reactions varies
    from 6 to 30, with at least 90 million courses
    of drug treatment given yearly
  • The reported percentage of patients who develop
    an adverse drug reaction during hospitalization
    varies markedly from 1.5 to 44,
  • Although in most studies the incidence is about
    10-20
  • It has been estimated that about one in 40
    consultations in general practice is the result
    of adverse drug reactions.
  • the percentage of consultations involving an
    adverse drug reaction increased from 0.6 for
    patients aged 0-20 years to 2.7 for patients
    aged over 50 years

6
  • The elderly persons have a significantly higher
    incidence of adverse drug reactions, related to
    decreased organ reserve capacity
  • Altered pharmacokinetics and pharmacodynamics,
  • polypharmacy

7
Classification of adverse drug reactions.
  • Non-immunological
  • Predictable
  • Overdosage
  • Side-effects
  • Cumulation
  • Delayed toxicity
  • Facultative effects
  • Drug interactions
  • Metabolic alterations
  • Teratogenicity
  • Non-immunological activation of effectors
    pathways
  • Exacerbation of disease
  • Drug-induced chromosomal damage
  • Unpredictable
  • Intolerance
  • Idiosyncrasy

8
Immunological (unpredictable)
  • IgE-dependent drug reactions
  • Immune complex-dependent drug reactions
  • Cytotoxic drug-induced
  • Cell-mediated reactions
  • Miscellaneous
  • Jarisch-Herxheimer reactions
  • Infectious mononucleosis-ampicillin reaction

9
Immunological drug reactions
  • IgE-dependent (type I) drug reactions
  • urticaria and anaphylaxis
  • Antibody-mediated (type II) drug reactions
  • Immune complex-dependent (type III)
  • Vasculitis
  • The Arthus reaction
  • Cell-mediated reactions (type IV reactions)
  • Erythema multiforme
  • Stevens-Johnson syndrome
  • Toxic epidermal necrolysis
  • "Lichenoid drug eruptions
  • Lupus erythematosus (LE)-like syndrome induced by
    drugs
  • Drug-induced pemphigus Pemhigoid
  • Fixed drug eruptions

10
Drugs causing exanthematic reactions.
  • Ampicillin and penicillin
  • Cephalosporins
  • Phenylbutazone and other pyrazolones
  • Barbiturates
  • Sulphonamides
  • Thiazides
  • Phenytoin
  • Naproxen
  • Carbamazepine
  • Isoniazid
  • Gold
  • Phenothiazines
  • Gentamicin

11
exanthematous reactions
12
exanthematous reactions
13
urticaria or anaphylaxis
  • Drugs causing are
  • Animal sera
  • Dextrans
  • Antibiotics
  • Angiotensin converting enzyme inhibitors
  • Vasopressin
  • Radiographic contrast media
  • Non-steroidal anti-inflammatory drugs
  • opiates, codeine, amphetamine, polymyxin B,
    tubocurarine, atropine, hydralazine, pentamidine,
    quinine and radiocontrast media - may release
    mast-cell mediators directly.
  • Cyclo-oxygenase inhibitors, such as aspirin and
    indomethacin,

14
(No Transcript)
15
Drugs causing photosensitivity.
  • Amiodarone
  • Ampicillin
  • Phenothiazines
  • Antidepressants
  • ChlorpromazineTetracyclines
  • Griseofulvin
  • Demeclocyclin

16
lichenoid eruptions
  • Drugs causing lichenoid eruptions.
  • Antitubercular drugs
  • Ethambutol
  • Antimalarials
  • Mepacrine (quinacrine, atebrin)
  • Frusemide,
  • diazoxide,
  • tetracyclines,

17
STEVENS-JOHNSON SYNDROME (S.J.S)TOXIC
EPIDERMAL NECROLYSIS (TEN)
18
(No Transcript)
19
MULTIPLE MUCOSAL LESION
20
SjS-TEN
21
SJS-TEN
22
STEVENS-JOHNSON SYNDROME (S.J.S)TOXIC
EPIDERMAL NECROLYSIS (TEN)
  • Anti-epileptic drugs (phenytoin, barbiturates,
    carbamazepine and lamotrigine
  • Ampicillin and other lactam antibiotics
  • Sulphonamides (sulphadiazine, trimethoprim-sulpham
    ethoxazole, sulphadoxine),
  • phenobarbital,
  • chlormezanone

23
Drugs reported to exacerbate psoriasis
  • Antimalarials
  • Lithium salts
  • Non-steroidal anti-inflammatory drugs
  • Buprofen
  • Indomethacin
  • Meclofenamate sodium
  • Pyrazolon derivatives (phenylbutazone,
    oxyphenbutazone)

24
Acne form eruption
  • Lesions are papulopustular but comedones are
    usually absent.
  • Adrenocorticotrophic hormone (ACTH),
    corticosteroids
  • Dexamethasone in neurosurgical patients,
  • Anabolic steroids for bodybuilding
  • Isoniazid may induce acne
  • Danazol

25
(No Transcript)
26
Fixe drug eruptions
  • Fixed eruptions characteristically recur in the
    same site or sites each time the drug is
    administered
  • Cross-sensitivity to related drugs may occur,
    such as between phenylbutazone and
    oxyphenbutazone and between tetracycline type
    drugs.
  • Acute lesions usually develop 30 min to 8h after
    drug administration
  • sharply marginated, round or oval itchy plaques
    of erythema and oedema becoming dusky violaceous
    or brown, and sometimes vesicular or bullous
  • Lesions are solitary at first, but with repeated
    attacks new lesions usually appear and existing
    lesions may increase in size.
  • Bullous fixed drug eruption
  • Co-trimoxazole (trimethoprim-sulphamethoxazole),
  • Tetracycline
  • Ampicilline

27
FDE GENITEL LESION
28
FDE
29
  • Hair changes
  • Drug-induced alopecia
  • Drug-induced hypertrichosis
  • Drug-induced hair discoloration
  • Nail changes
  • Onycholysis
  • Oral conditions
  • Xerostomia

30
The management of drug reactions
  • Diagnosis
  • Drug history
  • Drug elimination
  • Skin testing
  • Patch testing
  • In vitro tests
  • Tests for IgE antibody - RAST

31
  • Challenge tests
  • Treatment
  • Anaphylaxis
  • Exfoliative dermatitis/erythroderma
Write a Comment
User Comments (0)
About PowerShow.com